Tag: Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases
UofL researchers advocate clinical trials for CBD in COVID-19 treatment
An interdisciplinary team of researchers from several institutions headed by the University of Chicago and including the University of Louisville has found evidence that...
Latest round of Co-Immunity Project testing shows steep increase in COVID-19...
LOUISVILLE, Ky. – Results from the latest round of testing performed as part of the University of Louisville’s groundbreaking project to track COVID-19 in...
Phase I results of UofL Health’s Co-Immunity Project show precautions work...
Results from the first phase of the University of Louisville’s groundbreaking project to track COVID-19 in Metro Louisville show that precautionary measures to prevent...
Potential UofL coronavirus breakthrough in development with California biomedical company
A promising University of Louisville technology believed to block the novel coronavirus SARS-CoV-2 from infecting human cells now has a commercial partner.
The California biomedical...
UofL increases capacity for processing coronavirus test results
As coronavirus cases continue to spread throughout the commonwealth, the University of Louisville has ramped up its efforts to combat the deadly pandemic.
UofL researchers...
UofL’s nationally networked lab enables researchers to safely study coronavirus
A decade ago, when the National Institutes of Health needed to place a high-security biocontainment laboratory in Kentucky, capable of safely studying dangerous and...